This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Dasatinib-resistant and dasatinib-sensitive pancreatic cancer cell lines |
| Accession | GDS5627 |
| Summary | Analysis of dasatinib-resistant and dasatinib-sensitive PC cell lines. Dasatinib, a small-molecule kinase inhibitor, is FDA-approved for PC, but certain PC cells can have intrinsic or acquired resistance to dasatinib. Results provide insight into molecular basis of dasatinib-resistance in PC cells. |
| Organism | Homo sapiens |
| Platform | GPL10558 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Cell | Pancreas |
| Perturbation | Dasatinib |
| Disease | Resistant vs Sensitive (pancreatic cancer cell lines) |
| Principal Component Analysis | |
| Hierarchical clustering |
| Gene lists | Enrichr | L1000CDS2 | PAEA | |
| Up |
|
|||
| Down |
|
|||
| Combined |
|
|
|
